Neutralizing potential of Fab IgG hybrid antibody against dengue virus (DENV-1,2,3,4) expressed on mesenchymal stem cells

Keyphrases

• Dengue Virus 100%
• Mesenchymal Stem Cells 100%
• IgG Antibody 100%
• DENV-1 100%
• Dengue Infection 66%
• Virus 33%
• Indonesia 33%
• Human Mesenchymal Stem Cells (hMSCs) 33%
• Dengue Fever 33%
• High Affinity 33%
• DENV-2 33%
• Ligation 33%
• Dengue 33%
• Difficult-to-treat 33%
• Viral 33%
• Western Blotting 33%
• Dengue Virus Serotype 1 33%
• Viral Infection 33%
• Gene Coding 33%
• Binding Capacity 33%
• DENV-3 33%
• Rat Bone Marrow Mesenchymal Stem Cells 33%
• Binding Ability 33%
• Dengue Serotypes 33%
• Virus Neutralization 33%
• DENV-4 33%
• Binding Specificity 33%
• PBR322 33%
• Immune Precipitation 33%
• Antibody Fragment 33%
• High Reactivity 33%
• Neutralizing Agent 33%

Immunology and Microbiology

• Dengue Fever 100%
• Dengue Virus 1 100%
• Dengue Virus 100%
• Mesenchymal Stem Cell 100%
• Serotype 75%
• Immunoglobulin G Antibody 75%
• Viral Disease 50%
• Plasmid 25%
• Dengue Virus 2 25%
• Hemorrhagic Fever 25%
• ELISA 25%
• Western Blot 25%
• Neutralization 25%
• Dengue Virus 3 25%
• Dengue Virus 4 25%
• Immunoprecipitation 25%
• Virus 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Dengue 100%
• Dengue Virus 100%
• Dengue Virus 1 100%
• Immunoglobulin G Antibody 100%
• Virus Infection 66%
• Enzyme-Linked Immunosorbent Assay 33%
• Infection 33%
• Western Blot 33%
• Dengue Virus 2 33%
• Dengue Hemorrhagic Fever 33%
• Dengue Virus 3 33%
• Dengue Virus 4 33%
• Diseases 33%